首页
Rx
LP

Luye Pharma Group

204
16
2
3.7(69)

关于公司

  • 法定名称: Luye Pharma Group
  • 国际名称: 绿叶制药集团 (Luye Pharma Group Ltd.), Yantai and Shanghai, China
  • 品牌 / 商号: Luye Pharma
  • 注册国家: China
  • 地址: ShandongYantaiNo. 9, Baoyuan Road, Laishan District, Yantai City, Shandong Province • Shandong
描述:

Luye Pharma Group, established in 1994 in China and listed on the Hong Kong Stock Exchange, develops, produces, and markets innovative pharmaceutical products focused on oncology, cardiovascular disease, and alimentary tract/metabolism, with central nervous system disorders emerging as a growing focus area. The company pioneered China's first liposome industrialization breakthrough and developed proprietary continuous dynamic preparation technology for microspheres, leading internationally in long-acting microsphere treatments for neurodegenerative diseases, alongside internationally marketed Paclitaxel liposome formulations. Through acquisitions — including Nanjing Kanghai and Cisco Pharmaceutical (2007), the transdermal drug-delivery business of Swiss group Acino (2016), and rights to AstraZeneca's Seroquel and its slow-release tablets across 51 countries (2018) — Luye has expanded from its Yantai, Shandong origins into mainstream European and US markets, with production lines passing EU GMP inspection in 2013. Offering CRO services and backed by an experienced, internationally certified R&D team, the company distributes its rich portfolio of finished dosage forms, APIs, and bio products across Central/South America, Eastern Europe, Asia, the Middle East, North America, and Western Europe.

业务活动

成品制剂

制造商

给药系统

制造商

生物制药产品

生物技术/生物制药公司代理/代表出口商制造商

ATC(解剖学-治疗学-化学)分类系统

制造商代理/代表出口商

原料药 (API)

代理/代表制造商出口商

辅料与添加剂

出口商代理/代表制造商
销售市场
主要产品/服务

我们的产品与服务

Sell · ATC (Anatomical Therapeutic Chemical) Classification
Erzofri
筛选:
排序方式:

    暂无评论。